Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
10.06
-0.19 (-1.85%)
At close: Feb 12, 2026, 4:00 PM EST
9.86
-0.20 (-1.99%)
After-hours: Feb 12, 2026, 6:49 PM EST

Anika Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
145241332432517643
Market Cap Growth
-40.83%-27.34%-23.28%-16.40%-19.60%-13.05%
Enterprise Value
112206290376447567
Last Close Price
10.0616.4622.6629.6035.8345.26
PE Ratio
----125.13-
Forward PE
55.8939.19---62.00
PS Ratio
1.292.012.753.803.504.93
PB Ratio
0.991.571.561.511.802.36
P/TBV Ratio
1.061.671.642.122.633.72
P/FCF Ratio
223.88---158.9656.25
P/OCF Ratio
17.8444.62-98.0861.6049.24
PEG Ratio
----161.403.10
EV/Sales Ratio
0.991.722.403.303.034.34
EV/EBITDA Ratio
-56.8818.3720.70194.39151.74
EV/EBIT Ratio
--182.42102.39--
EV/FCF Ratio
172.21---137.5149.55
Debt / Equity Ratio
0.170.170.130.110.070.08
Debt / EBITDA Ratio
108.083.481.421.444.123.52
Debt / FCF Ratio
37.82---6.441.96
Net Debt / Equity Ratio
-0.23-0.19-0.19-0.19-0.26-0.28
Net Debt / EBITDA Ratio
9.13-8.19-2.59-3.05-31.90-20.31
Net Debt / FCF Ratio
-51.6712.745.6818.02-22.57-6.63
Asset Turnover
0.540.510.390.330.410.38
Inventory Turnover
1.801.801.171.071.421.80
Quick Ratio
4.203.403.064.334.173.32
Current Ratio
5.324.885.266.075.664.81
Return on Equity (ROE)
-8.73%-4.82%-1.38%0.77%1.48%-8.55%
Return on Assets (ROA)
-3.50%-1.19%0.32%0.66%-2.11%-1.75%
Return on Invested Capital (ROIC)
-10.13%-3.04%-0.86%0.84%-5.86%-6.03%
Return on Capital Employed (ROCE)
-6.90%-2.50%0.70%1.10%-3.80%-3.00%
Earnings Yield
-22.77%-23.39%-24.92%-3.44%0.80%-3.73%
FCF Yield
0.45%-0.97%-2.17%-0.71%0.63%1.78%
Buyback Yield / Dilution
2.20%-0.44%-0.65%0.50%-2.90%1.06%
Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q